Profiles, photos and behind-the-scenes interviews show how these leaders are uniquely poised to change pharmaceutical industry
NEW YORK, July 30, 2013 /PRNewswire/ — PHARMACEUTICAL EXECUTIVE, the biopharmaceutical industry's premier publication, celebrates 15 winners in its annual "Emerging Pharma Leaders" competition on the cover of its July issue.
The 15 new trendsetters, in many ways, reflect an industry that is changing from Big Pharma to what PHARMACEUTICAL EXECUTIVE characterizes as "growing to be small."
Who are the faces of the future? And what make them uniquely qualified to navigate a new business model through a leaner, faster, more challenging, competitive, collaborative and patient-oriented playing field?
Their backgrounds are diverse. Their stories are compelling, and their profiles representative of both the industry and the times. They are quick, agile, knowledgeable, tech savvy, multi-talented and modern.
A monthly magazine and daily online publication, PHARMACEUTICAL EXECUTIVE, offers policy analysis and in-depth business coverage of the global biopharmaceutical, vaccine and medical device industries.
[http://www.tinyurl.com/mrxqmv8]
EDITOR WILLIAM LOONEY ON PHARMACEUTICAL EXECUTIVE'S SELECTION OF 15 EMERGING LEADERS FOR JULY'S COVER STORY:
"For the first time, we include line executives from generic medicines and vaccines, two adjacent business units which under turbulent market conditions have emerged as key sources of product and process innovation," says Looney.
"Several of this year's winners have graduated to new roles that reflect the growing importance the 'c suite' places on knowledge retention, information services and the seeding of skills and talent throughout the organization.
"Other recipients hold positions that reflect the need for active, institutionalized collaboration between the R&D and commercial product teams, at the earliest stage of the development cycle.
"And in a business where customer insight is still in short supply, we find more leaders are entering the industry with valuable outside exposure to the fickle affiliations of the retail trade."
PHARMACEUTICAL EXECUTIVE'S 15 trendsetters also reflect a diversity and dynamism that's a surprising shift from the cliche of the complacent Big Pharma executive on the golf course collecting mulligans.
WILLIAM LOONEY adds: "Our selection showcases the immigrant experience, particularly how the contributions of newcomers adds to our nation's capacity to innovate. Outside interests range from the new age virtues of daily meditation to advocacy for same sex marriage."
[http://www.tinyurl.com/kdg6xqn]
For more information contact: William Looney, (212)-951-6735